Literature DB >> 18408111

Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis.

V S Sangle, S R Sangle, D P D'Cruz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18408111     DOI： 10.1136/ard.2007.073221

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  3 in total

1.  Cutaneous manifestations of dermatomyositis and their management.

Authors:  Jeffrey P Callen
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

2.  Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis.

Authors:  Alberto O Orden; Juan C Chuluyan; Ana C Colombini; Rubén F Barbera
Journal:  Rheumatol Int       Date:  2011-01-18       Impact factor: 2.631

3.  Genetic association study of NF-κB genes in UK Caucasian adult and juvenile onset idiopathic inflammatory myopathy.

Authors:  Hector Chinoy; Charles K-C Li; Hazel Platt; Noreen Fertig; Hemlata Varsani; Harsha Gunawardena; Zoe Betteridge; Chester V Oddis; Neil J McHugh; Lucy R Wedderburn; William E R Ollier; Robert G Cooper
Journal:  Rheumatology (Oxford)       Date:  2011-12-30       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.